At an upcoming conference offered by the University of Pennsylvania (Penn), experts will share the latest approaches and techniques for…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A newly discovered mutation in a gene called USP8Â may contribute to the development of pituitary tumors, which are the underlying…
Analyzing small amounts of tumor DNA that end up in the bloodstream could be useful for assessing the course of…
People with Cushing’s disease who are treated with Isturisa (osilodrostat) should be monitored for the possibility of developing…
Thyrotoxicosis, or abnormally high levels of thyroid hormones in the body, is a rare complication that can occur in people…
Measuring the levels of the RNA molecule that provides instructions to make a protein called FKBP5 could be useful for…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
The U.S. Patent and Trademark Office has issued a new patent to Strongbridge Biopharma that covers a method of…
Xeris Pharmaceuticals and Strongbridge Biopharma have entered an agreement in which Xeris will acquire Strongbridge, forming a new…
Sparrow Pharmaceuticals is planning to launch a Phase 2 clinical trial to assess the safety and effectiveness of its…